lilly tirzepatide vials launches of weight-loss drug Zepbound for as low as $399 a month Eli Lilly's Zepbound available in

The Phase 2 obesity trial published in the New England Journal of Medicine reported substantial weight reduction over 48 weeks, while a separate Phase 2 trial in people with type 2 diabetes evaluated glycemic and body-weight effects

Dyck, who is the Canada Research Chair in Molecular Medicine and heads up the Cardiovascular Research Centre, says his team did not observe any detrimental functional effects in the hearts of mice with smaller hearts and thus would not expect any overt health effects in humans

if you use one, check it carefully

Compared with placebo, semaglutide treatment obtained a higher achievement of the goal of 5% (RR 300, 95% CI 253 to 356

P values for each pairwise comparison (sham vs

Many people starting injectable medications experience significant nervousness